What is kernicterus and how is it related to HDN?

Kernicterus is a rare but serious form of brain damage caused by extremely high bilirubin levels. When red blood cells break down, they release bilirubin, a yellow pigment. If bilirubin reaches dangerous levels in newborns with HDN, it can cross into the brain and cause permanent damage. Early treatment with phototherapy and close monitoring prevent this complication in most cases.

Hemolytic Disease of the Newborn (HDN)/Erythroblastosis Fetalis

What is Hemolytic Disease of the Newborn (HDN)/Erythroblastosis Fetalis?

Hemolytic disease of the newborn is a serious blood condition that happens when a pregnant person's blood type does not match their baby's blood type. When this mismatch occurs, the mother's immune system can make antibodies that attack and destroy the baby's red blood cells. This process is called hemolysis, which means breaking down red blood cells.

The most common cause is Rh incompatibility, which happens when an Rh-negative mother carries an Rh-positive baby. Another cause is ABO incompatibility, which occurs when a mother with type O blood carries a baby with type A or type B blood. The mother's antibodies cross the placenta and damage the baby's blood cells, leading to anemia, jaundice, and other serious complications.

This condition used to be called erythroblastosis fetalis because it causes immature red blood cells called erythroblasts to appear in the baby's bloodstream. Today, most cases can be prevented with simple blood testing during pregnancy and a medication called RhoGAM for Rh-negative mothers. Early detection and treatment save lives and prevent long-term health problems in newborns.

Know Your Blood Type

Check your blood match for transfusions
Identify your risk during pregnancy issues
Analyze safe donation or receiving options

^$99

Male Ultimate Anti-Aging Panel

Checks for hormone balance
Monitors overall male health
Evaluates aging-related markers

^$451

Symptoms

Yellowing of the skin and whites of the eyes, known as jaundice
Pale skin color due to severe anemia
Enlarged liver or spleen that can be felt during examination
Rapid heart rate or breathing difficulties
Swelling throughout the body, a severe condition called hydrops fetalis
Low muscle tone or lethargy in the newborn
Difficulty feeding or poor weight gain
Dark-colored urine or pale stools

Some babies with mild cases may show few symptoms at birth. Signs often appear within the first 24 to 48 hours after delivery. Severe cases can cause complications before birth that may be detected during prenatal ultrasounds.

Causes and risk factors

Hemolytic disease of the newborn is caused by blood type incompatibility between mother and baby. The most common cause is Rh incompatibility, where an Rh-negative mother develops antibodies against an Rh-positive baby. This usually happens after the mother's first exposure to Rh-positive blood, either from a previous pregnancy, miscarriage, abortion, or blood transfusion. The antibodies remain in the mother's body and can attack the blood cells of Rh-positive babies in future pregnancies. ABO incompatibility occurs when a mother with type O blood carries a baby with type A, B, or AB blood. Her naturally occurring antibodies can cross the placenta and cause mild to moderate hemolysis.

Risk factors include previous pregnancies where blood mixing occurred, especially if the mother did not receive RhoGAM prevention. Events that increase blood mixing between mother and baby include trauma to the abdomen, amniocentesis or other invasive prenatal procedures, placental problems, and manual removal of the placenta after delivery. Women who have never been pregnant or received blood transfusions have lower risk. Regular prenatal care and blood type testing help identify at-risk pregnancies early.

How it's diagnosed

Diagnosis begins with blood type testing for both parents during early pregnancy. All pregnant people should have their ABO blood type and Rh factor tested at their first prenatal visit. If the mother is Rh-negative or has type O blood, additional antibody screening tests are performed throughout pregnancy to check if she has developed antibodies against the baby's blood type. These tests are typically done around 28 weeks of pregnancy and again before delivery.

Rite Aid offers ABO Blood Type and Rh Factor testing as an add-on to help identify blood type incompatibility risks. After birth, doctors diagnose HDN through newborn blood tests that check for anemia, bilirubin levels, and the presence of maternal antibodies on the baby's red blood cells. A positive direct Coombs test confirms that antibodies are attached to the baby's blood cells. Ultrasounds during pregnancy can detect severe cases by showing fluid buildup or an enlarged liver and spleen in the fetus.

Treatment options

Prevention with RhoGAM injections for Rh-negative mothers at 28 weeks of pregnancy and within 72 hours after delivery
Phototherapy using special blue lights to break down excess bilirubin and treat jaundice
Intravenous immunoglobulin to reduce antibody activity and slow red blood cell destruction
Exchange transfusions to replace damaged blood cells with healthy donor blood in severe cases
Blood transfusions during pregnancy for fetuses with severe anemia
Early delivery if the baby is mature enough and continuing pregnancy poses risks
Close monitoring of bilirubin levels after birth to prevent brain damage from kernicterus
Supportive care including fluids, temperature regulation, and feeding support

Frequently asked questions

Yes, HDN caused by Rh incompatibility can be prevented in most cases. Rh-negative mothers receive RhoGAM injections during pregnancy and after delivery to prevent antibody formation. This medication has dramatically reduced severe cases of HDN since its introduction in the 1960s. Early blood type testing and proper prenatal care are essential for prevention.

ABO incompatibility typically causes milder disease than Rh incompatibility and can occur during a first pregnancy. Mothers with type O blood have naturally occurring antibodies that can affect type A or B babies. Rh incompatibility usually requires prior exposure to develop antibodies and often causes more severe disease. There is no prevention medication for ABO incompatibility, but cases are generally easier to treat.

Not necessarily. If you are Rh-negative and receive RhoGAM as directed, your future Rh-positive babies should not be affected. Each pregnancy needs proper monitoring and prevention measures. If you have type O blood and previous babies had ABO incompatibility, future babies with type A or B blood may also be affected, but cases are usually mild and treatable.

Symptoms usually appear within the first 24 to 48 hours after birth. Jaundice is often the first visible sign, appearing as yellowing of the skin and eyes. Some babies show signs of anemia like pale skin and rapid breathing immediately after delivery. Severe cases may be detected before birth through ultrasound findings of fluid accumulation or organ enlargement.

Most babies with mild to moderate HDN recover fully with prompt treatment and have no long-term effects. Severe cases that are not treated quickly can lead to hearing loss, developmental delays, or cerebral palsy from kernicterus. Early detection through blood type testing, proper monitoring, and timely treatment prevent most serious complications. Regular follow-up care ensures healthy development.

Yes, knowing both parents' blood types helps assess risk for HDN. If you are Rh-negative and your partner is Rh-positive, your baby may be Rh-positive and need prevention measures. If you have type O blood and your partner has type A, B, or AB, there is risk for ABO incompatibility. Blood type testing before or early in pregnancy allows for proper planning and prevention.

Your healthcare team will monitor the baby closely with regular ultrasounds and antibody level checks. Mild cases may only need extra monitoring, while severe cases might require intrauterine blood transfusions to treat fetal anemia. Your doctor may recommend early delivery if the baby is mature enough and continuing pregnancy poses greater risks. A specialized care plan ensures the best outcome for mother and baby.

Yes, phototherapy is very safe and highly effective for treating jaundice in newborns. Special blue lights break down bilirubin in the skin so the body can eliminate it more easily. Babies lie under the lights wearing only a diaper and protective eye covers. Most babies need phototherapy for just a few days with no side effects or long-term concerns.

Yes, breastfeeding is safe and encouraged for babies with HDN. Breast milk does not worsen the condition and provides important nutrition and antibodies for your baby's recovery. Some babies with HDN may be sleepy or have difficulty feeding initially, so you may need extra support. Lactation consultants can help ensure your baby gets enough nutrition during treatment and recovery.